Fruit Street Health sues Sharecare for $25M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Fruit Street Health Sues Sharecare for $25M Fruit Street Health's complaint alleged that Sharecare violated the terms of their shared business agreement by rolling out its own version of Fruit Street's diabetes prevention program, which had been previously offered to Sharecare members. Sharecare said that the lawsuit is baseless. Sponsored Content Revolutionizing Virtual Primary Care Presented by MDLive and MedCity News MDLive President, Jon Salon details the latest enhancement to their virtual primary care offerings with chronic conditions and how the company's health coaching program will help patients stay engaged. Watch the full interview Extreme Early Bird Rate Ends Friday Night Time is running out, your chance to get the best rate on INVEST 2024 is ending Friday night. Don't miss your opportunity to secure your spot and save $700 off the full rate ticket price. Register Now

Featured News

Zocdoc CEO Predicts 5 Ways Patient Behavior Will Change in 2024 Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election. Privia Medical Group Teams Up with Iron Health To Advance OB/GYN Care Privia Medical Group Gulf Coast has launched Privia Wellness, which offers weight management, hormone replacement therapy, sleep and brain health and nutraceuticals. The weight management support is provided by Iron Health, a virtual care platform. Crossing the Interoperability Finish Line: Will TEFCA Help? TEFCA's goal is to establish a universal floor for interoperability across the country by developing the infrastructure model and governing approach for users in different networks to securely share basic clinical information with each other. With More 2024 FDA Filings Planned, Novartis Drug Starts Showing Blockbuster Potential Novartis drug iptacopan, which won its first FDA approval in early December in a rare blood disorder, has met the main goal of a pivotal test in an ultra-rare kidney disease. The small molecule's potential to address many diseases has stirred up blockbuster expectations. Connecting the Clinical Ecosystem to Alleviate Site Burden The future of clinical research is a connected user experience with automated workflows, streamlined document exchange and transparency to accelerate studies without compromising compliance. 4 Senators Urge CMS To Collect, Publish More Data on MA Plans In a letter to CMS, four senators asked for better data collection on the practices of Medicare Advantage plans, including when it comes to prior authorization.

Resources

How To Enable Hyperpersonal Care Amid transitioning consumer expectations, an evolving care delivery model, and a significant workforce crisis, health systems need to change the way they do business and harness the right technology to create an effective solution. This webinar will feature expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients and barriers that hold health systems back. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe